Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder characterized by persistent extreme hypertriglyceridemia as a result of lipoprotein lipase deficiency. Canada is an important region for FCS research due to the high prevalence rates. The burden of illness and quality of life of Canadian patients, however, have been inadequately addressed in the literature. The objective of this study is to understand the burden of illness of FCS on Canadian patients’ lives.
Authors
Daniel Gaudet, Michael Stevenson, Nelly Komari, Grace Trentin, Caroline Crowson, Nandini Hadker, Sophie Bernard
Journal
Lipids in Health and Disease